Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA mutations in the manifestation and treatment of ovarian cancer

30 May 2017

Abstract excerpt

// Zimin Pan 1 and Xing Xie 1 1 Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China Correspondence to: Xing Xie, email: xie.xing@yahoo.com Keywords: BRCA, ovarian cancer, pathogenesis, chemotherapy, targeted therapy Received: February 14, 2017 Accepted: April 28, 2017 Published: May 30, 2017 ABSTRACT BRCA genes are important for the integrity and...

Topics

Join the communities discussing this publication.

BRCA gene mutations in cancer
Ovarian cancer diagnosis and treatment
PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29228641
DOI: 10.18632/oncotarget.18280

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA mutations in the manifestation and treatment of ovarian cancerPMID 29228641Read ↗

BRCA-associated ovarian cancer: from molecular genetics to risk management.Semantic proximity Read ↗

Assessing Frequency and Clinical Outcomes of BRCA Mutated Ovarian Cancer in Saudi WomenSemantic proximity Read ↗

BRCA mutations: Implications of genetic testing in ovarian cancer.Semantic proximity Read ↗

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).Semantic proximity Read ↗

The clinical features associated with mutated BRCA1 and 2 genes in ovarian cancer patients.Semantic proximity Read ↗

Hereditary ovarian cancers: state of the artSemantic proximity Read ↗

Mutational profiles of ovarian cancer in Chinese patients reveal potential therapeutic targets and prognostic markersSemantic proximity Read ↗

Wise Management of Ovarian Cancer: On the Cutting EdgeSemantic proximity Read ↗

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read ↗

Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?Semantic proximity Read ↗

Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes.Semantic proximity Read ↗

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.